DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of RxSight
Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See www.faruqilaw.com.
As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: (1) the Company was experiencing 'adoption challenges' and/or structural issues resulting in declines in sales and utilization; (2) Defendants had overstated the demand for RxSight's products; (3) as a result, RxSight was unlikely to meet its own previously issued financial guidance for fiscal year 2025; and (4) that, as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
On July 8, 2025, after the market closed, RxSight reported preliminary second quarter 2025 financial results, revealing significant declines in LDD sales, LAL utilization, and overall revenue. The Company also lowered its full year 2025 guidance by approximately $42.5 million at the midpoint. The Company's Chief Executive Officer, Ronald Kurtz, disclosed that '[a]doption challenges over the last few quarters have been a primary reason for the LDD stall.'
On this news, RxSight's stock price fell $4.84, or 37.8%, to close at $7.95 per share on July 9, 2025, on unusually heavy trading volume.
The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not.
Faruqi & Faruqi, LLP also encourages anyone with information regarding RxSight's conduct to contact the firm, including whistleblowers, former employees, shareholders and others.
To learn more about the RxSight class action, go to www.faruqilaw.com/RXST or call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).
Follow us for updates on LinkedIn, on X, or on Facebook.
Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
33 minutes ago
- Yahoo
MercadoLibre (MELI) Q2 Earnings Report Preview: What To Look For
Latin American e-commerce and fintech company MercadoLibre (NASDAQ:MELI) will be reporting results this Monday afternoon. Here's what to expect. MercadoLibre beat analysts' revenue expectations by 8.1% last quarter, reporting revenues of $5.94 billion, up 37% year on year. It was a strong quarter for the company, with an impressive beat of analysts' EBITDA estimates and impressive growth in its users. It reported 66.6 million daily active users, up 24.5% year on year. Is MercadoLibre a buy or sell going into earnings? Read our full analysis here, it's free. This quarter, analysts are expecting MercadoLibre's revenue to grow 28.9% year on year to $6.54 billion, slowing from the 41.5% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $11.75 per share. Heading into earnings, analysts covering the company have grown increasingly bearish with revenue estimates seeing 3 downward revisions over the last 30 days (we track 7 analysts). MercadoLibre has a history of exceeding Wall Street's expectations, beating revenue estimates every single time over the past two years by 7.9% on average. Looking at MercadoLibre's peers in the online marketplace segment, some have already reported their Q2 results, giving us a hint as to what we can expect. Shutterstock delivered year-on-year revenue growth of 21.3%, beating analysts' expectations by 7.5%, and eBay reported revenues up 6.1%, topping estimates by 3.1%. Shutterstock's stock price was unchanged after the resultswhile eBay was up 18.5%. Read our full analysis of Shutterstock's results here and eBay's results here. Investors in the online marketplace segment have had steady hands going into earnings, with share prices flat over the last month. MercadoLibre is down 4.6% during the same time and is heading into earnings with an average analyst price target of $2,856 (compared to the current share price of $2,385). Today's young investors likely haven't read the timeless lessons in Gorilla Game: Picking Winners In High Technology because it was written more than 20 years ago when Microsoft and Apple were first establishing their supremacy. But if we apply the same principles, then enterprise software stocks leveraging their own generative AI capabilities may well be the Gorillas of the future. So, in that spirit, we are excited to present our Special Free Report on a profitable, fast-growing enterprise software stock that is already riding the automation wave and looking to catch the generative AI next. StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.
Yahoo
33 minutes ago
- Yahoo
Sterling (STRL) Reports Q2: Everything You Need To Know Ahead Of Earnings
Civil infrastructure construction company Sterling Infrastructure (NASDAQ:STRL) will be announcing earnings results this Monday after the bell. Here's what to look for. Sterling beat analysts' revenue expectations by 5.4% last quarter, reporting revenues of $430.9 million, down 2.1% year on year. It was a stunning quarter for the company, with full-year EBITDA guidance exceeding analysts' expectations and full-year revenue guidance exceeding analysts' expectations. Is Sterling a buy or sell going into earnings? Read our full analysis here, it's free. This quarter, analysts are expecting Sterling's revenue to decline 4.9% year on year to $554.4 million, a reversal from the 11.6% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $2.25 per share. The majority of analysts covering the company have reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Sterling has missed Wall Street's revenue estimates four times over the last two years. Looking at Sterling's peers in the construction and engineering segment, some have already reported their Q2 results, giving us a hint as to what we can expect. EMCOR delivered year-on-year revenue growth of 17.4%, beating analysts' expectations by 4.9%, and MasTec reported revenues up 19.7%, topping estimates by 4.2%. EMCOR traded down 2.3% following the results while MasTec was also down 8%. Read our full analysis of EMCOR's results here and MasTec's results here. Investors in the construction and engineering segment have had steady hands going into earnings, with share prices flat over the last month. Sterling is up 11.1% during the same time and is heading into earnings with an average analyst price target of $256.33 (compared to the current share price of $263.30). Unless you've been living under a rock, it should be obvious by now that generative AI is going to have a huge impact on how large corporations do business. While Nvidia and AMD are trading close to all-time highs, we prefer a lesser-known (but still profitable) semiconductor stock benefiting from the rise of AI. Click here to access our free report on our favorite semiconductor growth story. StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
33 minutes ago
- Yahoo
Freshpet (FRPT) Q2 Earnings Report Preview: What To Look For
Pet food company Freshpet (NASDAQ:FRPT) will be announcing earnings results this Monday morning. Here's what you need to know. Freshpet beat analysts' revenue expectations by 1.4% last quarter, reporting revenues of $263.2 million, up 17.6% year on year. It was a mixed quarter for the company, with an impressive beat of analysts' adjusted operating income estimates but full-year revenue guidance missing analysts' expectations significantly. Is Freshpet a buy or sell going into earnings? Read our full analysis here, it's free. This quarter, analysts are expecting Freshpet's revenue to grow 14.2% year on year to $268.8 million, slowing from the 28.3% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $0.16 per share. Heading into earnings, analysts covering the company have grown increasingly bearish with revenue estimates seeing 9 downward revisions over the last 30 days (we track 13 analysts). Freshpet has missed Wall Street's revenue estimates twice over the last two years. Looking at Freshpet's peers in the perishable food segment, some have already reported their Q2 results, giving us a hint as to what we can expect. Fresh Del Monte Produce delivered year-on-year revenue growth of 3.8%, beating analysts' expectations by 2.2%, and Cal-Maine reported revenues up 72.2%, topping estimates by 21.3%. Fresh Del Monte Produce traded up 4.2% following the results while Cal-Maine was also up 13.6%. Read our full analysis of Fresh Del Monte Produce's results here and Cal-Maine's results here. Questions about potential tariffs and corporate tax changes have caused much volatility in 2025. While some of the perishable food stocks have shown solid performance in this choppy environment, the group has generally underperformed, with share prices down 2.4% on average over the last month. Freshpet is down 3% during the same time and is heading into earnings with an average analyst price target of $98.24 (compared to the current share price of $65.90). When a company has more cash than it knows what to do with, buying back its own shares can make a lot of sense–as long as the price is right. Luckily, we've found one, a low-priced stock that is gushing free cash flow AND buying back shares. Click here to claim your Special Free Report on a fallen angel growth story that is already recovering from a setback. StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
